Spermatogonial Differentiation Via Testicular Organoid

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

January 1, 2027

Conditions
Infertility, MaleGene AbnormalitySterility, Male
Interventions
GENETIC

Stem cell

Primary cell cultures of tissue cells will be established. Cell cultures will undergo genetic reprogramming to induce the long-term propagation of living cells.

GENETIC

Genetic Screening

Serum samples are processed through RNA sequencing to reveal known and novel infertility-related biomarkers and genes.

GENETIC

Genetic Reprogramming

Genes or gene products will be reinserted into cells to observe how the cells can be changed, or reprogrammed, into embryonic-like cells or into sperm precursor cells.

GENETIC

Cell Maturation

Genetically unmodified and modified cells are placed in a laboratory-based testicular environment to promote spermatogenesis into maturity.

Trial Locations (1)

94108

RECRUITING

The Turek Clinic, San Francisco

All Listed Sponsors
collaborator

The Turek Clinic, Inc

UNKNOWN

lead

CellARTs Inc.

INDUSTRY